copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Regeneron | Pushing the Bounds of Science Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
Regeneron Pharmaceuticals - Wikipedia Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for . . . 23andMe will be operated as a wholly owned direct or indirect subsidiary of Regeneron Pharmaceuticals, Inc and continue operations as a personal genomics service Regeneron’s purchase does not include 23andMe’s Lemonaid Health business Additional details about the company’s operating plans will be shared at time of closing
Regeneron Pharmaceuticals to buy 23andMe for $256M Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million The New York-based drugmaker is set to take over 23andMe after winning a
Investor Relations | Regeneron Pharmaceuticals Inc. The Investor Relations website contains information about Regeneron Pharmaceuticals Inc 's business for stockholders, potential investors, and financial analysts
About Regeneron | Our Company - Regeneron Pharmaceuticals Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases